Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
J Neurosci Methods. 2009 May 30;180(1):34-42. doi: 10.1016/j.jneumeth.2009.02.015
Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation
Neurobiol Aging. 2009 Mar;30(3):388-93. doi: 10.1016/j.neurobiolaging.2007.07.013
Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A B{alpha} Subunit Expression That Correlate with Enhanced Tau Phosphorylation
J Neurosci. 2008 Nov 5;28(45):11477-87. doi: 10.1523/JNEUROSCI.2816-08.2008.
MAPT S305I mutation: implications for argyrophilic grain disease.
Acta Neuropathol. 2008 Jul;116(1):103-18. doi: 10.1007/s00401-007-0322-6. Epub 2007 Dec 8.
Inhibition of PHF-like Tau Hyperphosphorylation in SH-SY5Y Cells and Rat Brain Slices by K252a
Journal of Alzheimer’s Disease; 13(3): 281-294. DOI: 10.3233/jad-2008-13306
The tau S305S mutation causes frontotemporal dementia with parkinsonism
European Journal of Neurology; 15(2): 156-161. doi: 10.1111/j.1468-1331.2007.02017.x